Skip to content

VIM DBS Respiratory Modulation: N-of-1 Trial

Respiratory Modulation by VIM Deep Brain Stimulation: N-of-1 Trial of Breath-holding and Peak Expiratory Flow

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05381688
Enrollment
0
Registered
2022-05-19
Start date
2021-09-09
Completion date
2022-07-31
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dystonic Tremor, Essential Tremor

Brief summary

Research from our group has demonstrated modulation of PEFR in patients with STN and PAG stimulation. However, the effect of VIM (motor thalamus) stimulation remains to be investigated. Our group has also been involved in research that indicates that VIM stimulation may reduce perception of breathlessness. However, methodological factors limit the conclusions that can be drawn from this prior work. N-of-1 trials, organised as a randomised multiphase crossover design, are uniquely well suited for DBS research where stimulation can be switched ON and OFF, and with simple tests that can be done quickly, multiple times. PEFR and breath-holding are simple tests that we will test in this way. Other respiratory tests will be carried out along side, as optional, in a single phase design. We aim to offer this study to a continuous cohort of patients scheduled to undergo VIM (ET/DT) DBS at our institution. We will establish a pre-operative baseline of respiratory function, and then perform the n-of-1 trial post-operatively, soon after the patient returns to hospital to receive their DBS programming.

Interventions

PROCEDUREVIM DBS

Stereotactic deep brain stimulation of ventral intermediate nucleus of thalamus

Sponsors

University of Oxford
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Scheduled for VIM DBS * Diagnosis of ET or DT

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Breath-hold (urge to breath)3 months post-operative, ON and OFF: randomised, cross over, 5-phase designTime from start of breath-hold to urge to breathe

Secondary

MeasureTime frameDescription
Breath-hold (break point)3 months post-operative, ON and OFF: randomised, cross over, 5-phase designTime from start of breath-hold to breakpoint
Peak Expiratory Flow Rate3 months post-operative, ON and OFF: randomised, cross over, 5-phase designMaximum PEFR of three trials
Dyspnoea-12 QuestionnaireBaseline and 3 months post-operativeDifference in D12 score
OscillometryBaseline and 3 months post-operative ON and OFFDifference in airway resistance
Maximum inspiratory pressureBaseline and 3 months post-operative ON and OFFBest MIP of three trials

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026